NXPI NXP Semiconductors | $249.43 -2.6% | 5/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $250.00 -> $295.00 | Low | View details for Oppenheimer rating of NXP Semiconductors (NASDAQ:NXPI) on 5/1/2024 |
RSG Republic Services | $186.00 -3.0% | 5/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $202.00 -> $204.00 | Low | View details for Oppenheimer rating of Republic Services (NYSE:RSG) on 5/1/2024 |
DAN Dana | $13.26 +6.7% | 5/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $17.00 -> $18.00 | Low | View details for Oppenheimer rating of Dana (NYSE:DAN) on 5/1/2024 |
DENN Denny's | $8.04 +0.2% | 5/1/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $12.00 -> $11.00 | Low | View details for Oppenheimer rating of Denny’s (NASDAQ:DENN) on 5/1/2024 |
TREE LendingTree | $47.89 -0.8% | 5/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $45.00 -> $55.00 | Low | View details for Oppenheimer rating of LendingTree (NASDAQ:TREE) on 5/1/2024 |
AMZN Amazon.com | $179.00 +2.3% | 5/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $210.00 -> $220.00 | Low | View details for Oppenheimer rating of Amazon.com (NASDAQ:AMZN) on 5/1/2024 |
|
TMDX TransMedics Group | $117.60 +24.9% | 5/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $105.00 -> $125.00 | Low | View details for Oppenheimer rating of TransMedics Group (NASDAQ:TMDX) on 5/1/2024 |
LOVE Lovesac | $22.03 -0.7% | 5/1/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $60.00 -> $35.00 | Low | View details for Oppenheimer rating of Lovesac (NASDAQ:LOVE) on 5/1/2024 |
DPZ Domino's Pizza | $516.42 -2.4% | 4/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $530.00 -> $580.00 | Low | View details for Oppenheimer rating of Domino’s Pizza (NYSE:DPZ) on 4/30/2024 |
GS The Goldman Sachs Group | $426.54 0.0% | 4/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $479.00 -> $517.00 | Low | View details for Oppenheimer rating of The Goldman Sachs Group (NYSE:GS) on 4/30/2024 |
JEF Jefferies Financial Group | $43.22 +0.4% | 4/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $54.00 -> $56.00 | Low | View details for Oppenheimer rating of Jefferies Financial Group (NYSE:JEF) on 4/30/2024 |
MS Morgan Stanley | $91.49 +0.7% | 4/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $101.00 -> $105.00 | Low | View details for Oppenheimer rating of Morgan Stanley (NYSE:MS) on 4/30/2024 |
BAC Bank of America | $36.95 -0.2% | 4/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $45.00 -> $46.00 | Low | View details for Oppenheimer rating of Bank of America (NYSE:BAC) on 4/30/2024 |
C Citigroup | $61.35 +0.0% | 4/30/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $87.00 -> $86.00 | Low | View details for Oppenheimer rating of Citigroup (NYSE:C) on 4/30/2024 |
CNC Centene | $72.25 -1.1% | 4/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $110.00 -> $110.00 | Low | View details for Oppenheimer rating of Centene (NYSE:CNC) on 4/29/2024 |
EXPE Expedia Group | $133.14 -1.1% | 4/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $175.00 -> $175.00 | Low | View details for Oppenheimer rating of Expedia Group (NASDAQ:EXPE) on 4/29/2024 |
ROP Roper Technologies | $514.76 +0.6% | 4/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $650.00 -> $650.00 | Low | View details for Oppenheimer rating of Roper Technologies (NYSE:ROP) on 4/29/2024 |
SFM Sprouts Farmers Market | $64.29 -2.6% | 4/29/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Sprouts Farmers Market (NASDAQ:SFM) on 4/29/2024 |
UBER Uber Technologies | $67.79 +2.3% | 4/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $90.00 | Low | View details for Oppenheimer rating of Uber Technologies (NYSE:UBER) on 4/29/2024 |
URI United Rentals | $653.76 -2.1% | 4/29/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of United Rentals (NYSE:URI) on 4/29/2024 |
WT WisdomTree | $8.97 +0.7% | 4/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $11.00 -> $11.00 | Low | View details for Oppenheimer rating of WisdomTree (NYSE:WT) on 4/29/2024 |
LECO Lincoln Electric | $219.33 -0.1% | 4/29/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Lincoln Electric (NASDAQ:LECO) on 4/29/2024 |
BIIB Biogen | $216.13 +0.6% | 4/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $270.00 -> $270.00 | Low | View details for Oppenheimer rating of Biogen (NASDAQ:BIIB) on 4/29/2024 |
DASH DoorDash | $127.46 -1.4% | 4/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $140.00 -> $150.00 | Low | View details for Oppenheimer rating of DoorDash (NASDAQ:DASH) on 4/29/2024 |
ETSY Etsy | $69.74 +1.6% | 4/29/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $95.00 -> $80.00 | Low | View details for Oppenheimer rating of Etsy (NASDAQ:ETSY) on 4/29/2024 |
HCA HCA Healthcare | $309.44 -0.1% | 4/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $330.00 -> $345.00 | Low | View details for Oppenheimer rating of HCA Healthcare (NYSE:HCA) on 4/29/2024 |
CART Maplebear | $35.46 +3.9% | 4/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $36.00 -> $48.00 | Low | View details for Oppenheimer rating of Maplebear (NASDAQ:CART) on 4/29/2024 |
OSIS OSI Systems | $131.07 -0.3% | 4/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $157.00 -> $160.00 | Low | View details for Oppenheimer rating of OSI Systems (NASDAQ:OSIS) on 4/29/2024 |
POOL Pool | $359.50 -0.8% | 4/29/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $436.00 -> $416.00 | Low | View details for Oppenheimer rating of Pool (NASDAQ:POOL) on 4/29/2024 |
GOOGL Alphabet | $163.86 +0.7% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $185.00 -> $205.00 | Low | View details for Oppenheimer rating of Alphabet (NASDAQ:GOOGL) on 4/26/2024 |
TEAM Atlassian | $172.77 +0.3% | 4/26/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $300.00 -> $250.00 | Low | View details for Oppenheimer rating of Atlassian (NASDAQ:TEAM) on 4/26/2024 |
CSL Carlisle Companies | $385.18 -0.8% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $412.00 -> $430.00 | Low | View details for Oppenheimer rating of Carlisle Companies (NYSE:CSL) on 4/26/2024 |
CARR Carrier Global | $61.12 -0.6% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $63.00 -> $64.00 | Low | View details for Oppenheimer rating of Carrier Global (NYSE:CARR) on 4/26/2024 |
DOV Dover | $177.85 -0.8% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $187.00 -> $197.00 | Low | View details for Oppenheimer rating of Dover (NYSE:DOV) on 4/26/2024 |
RMD ResMed | $214.96 +0.5% | 4/26/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $205.00 -> $200.00 | Low | View details for Oppenheimer rating of ResMed (NYSE:RMD) on 4/26/2024 |
SPGI S&P Global | $416.21 +0.1% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $480.00 -> $482.00 | Low | View details for Oppenheimer rating of S&P Global (NYSE:SPGI) on 4/26/2024 |
TDOC Teladoc Health | $12.81 +0.4% | 4/26/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $26.00 -> $21.00 | Low | View details for Oppenheimer rating of Teladoc Health (NYSE:TDOC) on 4/26/2024 |
TPH Tri Pointe Homes | $37.47 +1.7% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $41.00 -> $46.00 | Low | View details for Oppenheimer rating of Tri Pointe Homes (NYSE:TPH) on 4/26/2024 |
WM Waste Management | $206.71 -0.6% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $221.00 -> $228.00 | Low | View details for Oppenheimer rating of Waste Management (NYSE:WM) on 4/26/2024 |
TYL Tyler Technologies | $458.53 -0.7% | 4/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $480.00 -> $500.00 | Low | View details for Oppenheimer rating of Tyler Technologies (NYSE:TYL) on 4/26/2024 |
He Is Giving Away Bitcoin (Ad) And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously.
Right now is a very important time to pay attention to what we are doing and what is happening.
If you wait... it will be too late.
This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here |
VRT Vertiv | $88.55 -4.8% | 4/25/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $96.00 -> $98.00 | Low | View details for Oppenheimer rating of Vertiv (NYSE:VRT) on 4/25/2024 |
CMG Chipotle Mexican Grill | $3,138.66 -0.7% | 4/25/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $2,825.00 -> $3,300.00 | Low | View details for Oppenheimer rating of Chipotle Mexican Grill (NYSE:CMG) on 4/25/2024 |
CYH Community Health Systems | $3.44 +4.2% | 4/25/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $5.50 -> $4.50 | Low | View details for Oppenheimer rating of Community Health Systems (NYSE:CYH) on 4/25/2024 |
HUM Humana | $314.21 +4.0% | 4/25/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $415.00 -> $370.00 | Low | View details for Oppenheimer rating of Humana (NYSE:HUM) on 4/25/2024 |
META Meta Platforms | $439.19 +2.1% | 4/25/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $585.00 -> $500.00 | N/A | View details for Oppenheimer rating of Meta Platforms (NASDAQ:META) on 4/25/2024 |
ENPH Enphase Energy | $105.16 -3.3% | 4/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $133.00 -> $134.00 | Low | View details for Oppenheimer rating of Enphase Energy (NASDAQ:ENPH) on 4/24/2024 |
INCY Incyte | $52.94 +1.7% | 4/24/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $92.00 -> $84.00 | Low | View details for Oppenheimer rating of Incyte (NASDAQ:INCY) on 4/24/2024 |
NBIX Neurocrine Biosciences | $143.03 +4.0% | 4/24/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $200.00 -> $200.00 | Low | View details for Oppenheimer rating of Neurocrine Biosciences (NASDAQ:NBIX) on 4/24/2024 |
NEP NextEra Energy Partners | $28.60 +0.8% | 4/24/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of NextEra Energy Partners (NYSE:NEP) on 4/24/2024 |
PNR Pentair | $79.07 0.0% | 4/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $88.00 -> $90.00 | Low | View details for Oppenheimer rating of Pentair (NYSE:PNR) on 4/24/2024 |
PHM PulteGroup | $111.82 +0.4% | 4/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $138.00 -> $143.00 | Low | View details for Oppenheimer rating of PulteGroup (NYSE:PHM) on 4/24/2024 |
TSLA Tesla | $179.99 -1.8% | 4/24/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Tesla (NASDAQ:TSLA) on 4/24/2024 |
TXN Texas Instruments | $175.20 -0.7% | 4/24/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Texas Instruments (NASDAQ:TXN) on 4/24/2024 |
UPS United Parcel Service | $145.86 -1.1% | 4/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $153.00 -> $157.00 | Low | View details for Oppenheimer rating of United Parcel Service (NYSE:UPS) on 4/24/2024 |
V Visa | $267.32 -0.5% | 4/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $297.00 -> $299.00 | Low | View details for Oppenheimer rating of Visa (NYSE:V) on 4/24/2024 |
MSCI MSCI | $469.74 +0.8% | 4/24/2024 | Reiterated by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of MSCI (NYSE:MSCI) on 4/24/2024 |
EA Electronic Arts | $128.18 +1.1% | 4/23/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $150.00 -> $150.00 | Low | View details for Oppenheimer rating of Electronic Arts (NASDAQ:EA) on 4/23/2024 |
GANX Gain Therapeutics | $2.97 +1.4% | 4/23/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $9.00 | Low | View details for Oppenheimer rating of Gain Therapeutics (NASDAQ:GANX) on 4/23/2024 |
TTWO Take-Two Interactive Software | $142.74 0.0% | 4/23/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $185.00 | Low | View details for Oppenheimer rating of Take-Two Interactive Software (NASDAQ:TTWO) on 4/23/2024 |
VZ Verizon Communications | $39.19 -0.8% | 4/23/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $48.00 -> $48.00 | Low | View details for Oppenheimer rating of Verizon Communications (NYSE:VZ) on 4/23/2024 |
CHD Church & Dwight | $106.24 -1.5% | 4/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $110.00 -> $120.00 | Low | View details for Oppenheimer rating of Church & Dwight (NYSE:CHD) on 4/23/2024 |
ATRC AtriCure | $24.76 +2.7% | 4/23/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $32.00 | Low | View details for Oppenheimer rating of AtriCure (NASDAQ:ATRC) on 4/23/2024 |
TARA Protara Therapeutics | $2.93 -1.7% | 4/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $26.00 -> $30.00 | Low | View details for Oppenheimer rating of Protara Therapeutics (NASDAQ:TARA) on 4/22/2024 |
WT WisdomTree | $8.97 +0.7% | 4/22/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $12.00 -> $11.00 | Low | View details for Oppenheimer rating of WisdomTree (NYSE:WT) on 4/22/2024 |
KYMR Kymera Therapeutics | $36.24 +7.8% | 4/22/2024 | Initiated by | Oppenheimer | - | Outperform | $53.00 | Low | View details for Oppenheimer rating of Kymera Therapeutics (NASDAQ:KYMR) on 4/22/2024 |
GILD Gilead Sciences | $65.51 +0.5% | 4/19/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $105.00 | Low | View details for Oppenheimer rating of Gilead Sciences (NASDAQ:GILD) on 4/19/2024 |
NFLX Netflix | $551.71 +0.2% | 4/19/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $725.00 | Low | View details for Oppenheimer rating of Netflix (NASDAQ:NFLX) on 4/19/2024 |
SBUX Starbucks | $74.44 -15.9% | 4/19/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Starbucks (NASDAQ:SBUX) on 4/19/2024 |
BIIB Biogen | $216.13 +0.6% | 4/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $290.00 -> $270.00 | Low | View details for Oppenheimer rating of Biogen (NASDAQ:BIIB) on 4/19/2024 |
EFX Equifax | $220.67 +0.2% | 4/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $291.00 -> $272.00 | Low | View details for Oppenheimer rating of Equifax (NYSE:EFX) on 4/19/2024 |
USB U.S. Bancorp | $41.05 +1.0% | 4/18/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $55.00 -> $54.00 | Low | View details for Oppenheimer rating of U.S. Bancorp (NYSE:USB) on 4/18/2024 |
XYL Xylem | $130.96 +0.2% | 4/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $133.00 -> $142.00 | Low | View details for Oppenheimer rating of Xylem (NYSE:XYL) on 4/18/2024 |
SAGE Sage Therapeutics | $13.28 -4.7% | 4/18/2024 | Target Lowered by | Oppenheimer | - | Market Perform -> Market Perform | $25.00 -> $17.00 | Low | View details for Oppenheimer rating of Sage Therapeutics (NASDAQ:SAGE) on 4/18/2024 |
TRNS Transcat | $107.50 +0.1% | 4/18/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $120.00 -> $125.00 | Low | View details for Oppenheimer rating of Transcat (NASDAQ:TRNS) on 4/18/2024 |
AOS A. O. Smith | $82.79 -0.1% | 4/18/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of A. O. Smith (NYSE:AOS) on 4/18/2024 |
WMS Advanced Drainage Systems | $158.52 +1.0% | 4/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $172.00 -> $180.00 | Low | View details for Oppenheimer rating of Advanced Drainage Systems (NYSE:WMS) on 4/18/2024 |
AVNT Avient | $42.98 +1.3% | 4/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $45.00 -> $49.00 | Low | View details for Oppenheimer rating of Avient (NYSE:AVNT) on 4/18/2024 |
CSL Carlisle Companies | $385.18 -0.8% | 4/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $405.00 -> $412.00 | Low | View details for Oppenheimer rating of Carlisle Companies (NYSE:CSL) on 4/18/2024 |
CARR Carrier Global | $61.12 -0.6% | 4/18/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $63.00 | Low | View details for Oppenheimer rating of Carrier Global (NYSE:CARR) on 4/18/2024 |
CAT Caterpillar | $331.07 -1.0% | 4/18/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Caterpillar (NYSE:CAT) on 4/18/2024 |
DOV Dover | $177.85 -0.8% | 4/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $177.00 -> $187.00 | Low | View details for Oppenheimer rating of Dover (NYSE:DOV) on 4/18/2024 |
IEX IDEX | $221.38 +0.4% | 4/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $245.00 -> $252.00 | Low | View details for Oppenheimer rating of IDEX (NYSE:IEX) on 4/18/2024 |
JCI Johnson Controls International | $60.44 -7.1% | 4/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $66.00 -> $71.00 | Low | View details for Oppenheimer rating of Johnson Controls International (NYSE:JCI) on 4/18/2024 |
SPT Sprout Social | $49.91 -1.1% | 4/18/2024 | Initiated by | Oppenheimer | - | Outperform | $76.00 | Low | View details for Oppenheimer rating of Sprout Social (NASDAQ:SPT) on 4/18/2024 |
ORCL Oracle | $114.60 +0.7% | 4/18/2024 | Initiated by | Oppenheimer | - | Market Perform | | Low | View details for Oppenheimer rating of Oracle (NYSE:ORCL) on 4/18/2024 |
MWA Mueller Water Products | $15.91 +0.4% | 4/18/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $19.00 | Low | View details for Oppenheimer rating of Mueller Water Products (NYSE:MWA) on 4/18/2024 |
AMRC Ameresco | $20.48 -2.2% | 4/17/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Ameresco (NYSE:AMRC) on 4/17/2024 |
BLZE Backblaze | $9.32 +0.1% | 4/17/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $11.00 -> $13.00 | Low | View details for Oppenheimer rating of Backblaze (NASDAQ:BLZE) on 4/17/2024 |
BAC Bank of America | $36.95 -0.2% | 4/17/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $46.00 -> $45.00 | Low | View details for Oppenheimer rating of Bank of America (NYSE:BAC) on 4/17/2024 |
FSLR First Solar | $177.58 +0.7% | 4/17/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $269.00 | Low | View details for Oppenheimer rating of First Solar (NASDAQ:FSLR) on 4/17/2024 |
Trump just won 2024 (Ad) President Trump signed an executive order that ensures he’ll be remembered as one of America’s greatest Presidents.
It was an Executive Order that received almost no media attention… For the full story, click here. |
MS Morgan Stanley | $91.49 +0.7% | 4/17/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $97.00 -> $101.00 | Low | View details for Oppenheimer rating of Morgan Stanley (NYSE:MS) on 4/17/2024 |
PANW Palo Alto Networks | $287.34 -1.2% | 4/17/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $305.00 -> $330.00 | Low | View details for Oppenheimer rating of Palo Alto Networks (NASDAQ:PANW) on 4/17/2024 |
QMCO Quantum | $0.49 +2.1% | 4/17/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Quantum (NASDAQ:QMCO) on 4/17/2024 |
TWLO Twilio | $60.96 +1.8% | 4/17/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $75.00 | Low | View details for Oppenheimer rating of Twilio (NYSE:TWLO) on 4/17/2024 |
VIRX Viracta Therapeutics | $0.82
| 4/17/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $13.00 | Low | View details for Oppenheimer rating of Viracta Therapeutics (NASDAQ:VIRX) on 4/17/2024 |
OBDE Blue Owl Capital Co. III | $14.99 -0.3% | 4/17/2024 | Initiated by | Oppenheimer | - | Outperform | $16.00 | Low | View details for Oppenheimer rating of Blue Owl Capital Co. III (NYSE:OBDE) on 4/17/2024 |
SKIL Skillsoft | $7.47 +3.9% | 4/16/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Skillsoft (NASDAQ:SKIL) on 4/16/2024 |
AGCO AGCO | $112.14 -1.8% | 4/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $153.00 -> $154.00 | Low | View details for Oppenheimer rating of AGCO (NYSE:AGCO) on 4/16/2024 |
CNHI CNH Industrial | $11.33 -0.7% | 4/16/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of CNH Industrial (NYSE:CNHI) on 4/16/2024 |
CTVA Corteva | $53.90 -0.4% | 4/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $62.00 -> $67.00 | Low | View details for Oppenheimer rating of Corteva (NYSE:CTVA) on 4/16/2024 |
GS The Goldman Sachs Group | $426.54 0.0% | 4/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $446.00 -> $479.00 | Low | View details for Oppenheimer rating of The Goldman Sachs Group (NYSE:GS) on 4/16/2024 |
AVTX Avalo Therapeutics | $16.01 -6.5% | 4/16/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | | Low | View details for Oppenheimer rating of Avalo Therapeutics (NASDAQ:AVTX) on 4/16/2024 |
C Citigroup | $61.35 +0.0% | 4/15/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $88.00 -> $87.00 | Low | View details for Oppenheimer rating of Citigroup (NYSE:C) on 4/15/2024 |
EL Estée Lauder Companies | $127.37 -13.2% | 4/15/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Estée Lauder Companies (NYSE:EL) on 4/15/2024 |
JPM JPMorgan Chase & Co. | $191.86 +0.1% | 4/15/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $219.00 -> $217.00 | Low | View details for Oppenheimer rating of JPMorgan Chase & Co. (NYSE:JPM) on 4/15/2024 |
VRTX Vertex Pharmaceuticals | $402.14 +2.4% | 4/15/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $500.00 | Low | View details for Oppenheimer rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 4/15/2024 |
VERU Veru | $1.49 +10.4% | 4/15/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $7.00 -> $5.00 | Low | View details for Oppenheimer rating of Veru (NASDAQ:VERU) on 4/15/2024 |
WFC Wells Fargo & Company | $59.50 +0.3% | 4/15/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Wells Fargo & Company (NYSE:WFC) on 4/15/2024 |
ZWS Zurn Elkay Water Solutions | $31.33 +0.2% | 4/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $36.00 -> $37.00 | Low | View details for Oppenheimer rating of Zurn Elkay Water Solutions (NYSE:ZWS) on 4/12/2024 |
RVMD Revolution Medicines | $38.82 +4.1% | 4/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $43.00 -> $45.00 | Low | View details for Oppenheimer rating of Revolution Medicines (NASDAQ:RVMD) on 4/12/2024 |
SKYE Skye Bioscience | $12.79 -1.1% | 4/12/2024 | Initiated by | Oppenheimer | - | Outperform | $25.00 | Low | View details for Oppenheimer rating of Skye Bioscience (NASDAQ:SKYE) on 4/12/2024 |
SKYE Skye Bioscience | $12.79 -1.1% | 4/12/2024 | Initiated by | Oppenheimer | - | Outperform | $25.00 | Low | View details for Oppenheimer rating of Skye Bioscience (NASDAQ:SKYE) on 4/12/2024 |
QTTB Q32 Bio | $26.54 -3.1% | 4/11/2024 | Initiated by | Oppenheimer | - | Outperform | $50.00 | Low | View details for Oppenheimer rating of Q32 Bio (NASDAQ:QTTB) on 4/11/2024 |
LVRO Lavoro | $5.60
| 4/11/2024 | Initiated by | Oppenheimer | - | Outperform | $11.00 | Low | View details for Oppenheimer rating of Lavoro (NASDAQ:LVRO) on 4/11/2024 |
XPO XPO | $106.43 -1.0% | 4/10/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $130.00 -> $140.00 | Low | View details for Oppenheimer rating of XPO (NYSE:XPO) on 4/10/2024 |
KMX CarMax | $67.21 -1.1% | 4/9/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $105.00 | Low | View details for Oppenheimer rating of CarMax (NYSE:KMX) on 4/9/2024 |
CUE Cue Biopharma | $1.91 +0.5% | 4/9/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $10.00 | Low | View details for Oppenheimer rating of Cue Biopharma (NASDAQ:CUE) on 4/9/2024 |
EFX Equifax | $220.67 +0.2% | 4/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $273.00 -> $291.00 | Low | View details for Oppenheimer rating of Equifax (NYSE:EFX) on 4/9/2024 |
IONS Ionis Pharmaceuticals | $43.01 +4.2% | 4/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $72.00 -> $75.00 | Low | View details for Oppenheimer rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 4/9/2024 |
MSCI MSCI | $469.74 +0.8% | 4/9/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $659.00 -> $648.00 | Low | View details for Oppenheimer rating of MSCI (NYSE:MSCI) on 4/9/2024 |
SEIC SEI Investments | $66.21 +0.4% | 4/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $77.00 -> $80.00 | Low | View details for Oppenheimer rating of SEI Investments (NASDAQ:SEIC) on 4/9/2024 |
TRU TransUnion | $74.61 +2.2% | 4/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $81.00 -> $90.00 | Low | View details for Oppenheimer rating of TransUnion (NYSE:TRU) on 4/9/2024 |
APP AppLovin | $69.74 -1.2% | 4/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $70.00 -> $85.00 | Low | View details for Oppenheimer rating of AppLovin (NASDAQ:APP) on 4/8/2024 |
META Meta Platforms | $439.19 +2.1% | 4/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $525.00 -> $585.00 | Low | View details for Oppenheimer rating of Meta Platforms (NASDAQ:META) on 4/8/2024 |
GOOG Alphabet | $165.57 +0.6% | 4/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $172.00 -> $185.00 | Low | View details for Oppenheimer rating of Alphabet (NASDAQ:GOOG) on 4/8/2024 |
HCI HCI Group | $114.17 0.0% | 4/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $140.00 | Low | View details for Oppenheimer rating of HCI Group (NYSE:HCI) on 4/5/2024 |
THG The Hanover Insurance Group | $131.02 +0.9% | 4/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $150.00 | Low | View details for Oppenheimer rating of The Hanover Insurance Group (NYSE:THG) on 4/5/2024 |
SIGI Selective Insurance Group | $102.28 +0.6% | 4/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $120.00 | Low | View details for Oppenheimer rating of Selective Insurance Group (NASDAQ:SIGI) on 4/5/2024 |
LULU Lululemon Athletica | $354.40 -1.7% | 4/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $540.00 -> $445.00 | Low | View details for Oppenheimer rating of Lululemon Athletica (NASDAQ:LULU) on 4/5/2024 |
TRV Travelers Companies | $213.06 +0.4% | 4/5/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Travelers Companies (NYSE:TRV) on 4/5/2024 |
AXP American Express | $231.46 -1.1% | 4/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | | Low | View details for Oppenheimer rating of American Express (NYSE:AXP) on 4/5/2024 |
ANGO AngioDynamics | $5.79
| 4/5/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $12.00 | Low | View details for Oppenheimer rating of AngioDynamics (NASDAQ:ANGO) on 4/5/2024 |
VRT Vertiv | $88.55 -4.8% | 4/5/2024 | Initiated by | Oppenheimer | - | Outperform | $96.00 | Low | View details for Oppenheimer rating of Vertiv (NYSE:VRT) on 4/5/2024 |
GENI Genius Sports | $5.04
| 4/4/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $10.00 | Low | View details for Oppenheimer rating of Genius Sports (NYSE:GENI) on 4/4/2024 |
ULTA Ulta Beauty | $402.11 -0.7% | 4/4/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $600.00 -> $500.00 | Low | View details for Oppenheimer rating of Ulta Beauty (NASDAQ:ULTA) on 4/4/2024 |
COIN Coinbase Global | $210.09 +3.0% | 4/4/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $200.00 -> $276.00 | Low | View details for Oppenheimer rating of Coinbase Global (NASDAQ:COIN) on 4/4/2024 |
AYI Acuity Brands | $246.02 -0.9% | 4/4/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $250.00 -> $315.00 | Low | View details for Oppenheimer rating of Acuity Brands (NYSE:AYI) on 4/4/2024 |
BMEA Biomea Fusion | $11.57 +7.7% | 4/3/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $70.00 | Low | View details for Oppenheimer rating of Biomea Fusion (NASDAQ:BMEA) on 4/3/2024 |
CMCSA Comcast | $38.20 +0.2% | 4/3/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $55.00 | Low | View details for Oppenheimer rating of Comcast (NASDAQ:CMCSA) on 4/3/2024 |
STRO Sutro Biopharma | $3.74 +10.3% | 4/3/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $10.00 | Low | View details for Oppenheimer rating of Sutro Biopharma (NASDAQ:STRO) on 4/3/2024 |
The biggest energy story ever? (Ad) Discover why I’m calling this one of the biggest developments in the global energy market since the shale revolution… why everything you’ve ever been told about Trump’s environmental record is a lie… For the full story, click here. |
TMUS T-Mobile US | $165.47 +0.8% | 4/3/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $190.00 | Low | View details for Oppenheimer rating of T-Mobile US (NASDAQ:TMUS) on 4/3/2024 |
VZ Verizon Communications | $39.19 -0.8% | 4/3/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $48.00 | Low | View details for Oppenheimer rating of Verizon Communications (NYSE:VZ) on 4/3/2024 |
ALDX Aldeyra Therapeutics | $4.20 +6.6% | 4/3/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $10.00 | Low | View details for Oppenheimer rating of Aldeyra Therapeutics (NASDAQ:ALDX) on 4/3/2024 |
AIT Applied Industrial Technologies | $180.67 -1.4% | 4/2/2024 | Initiated by | Oppenheimer | - | Outperform | $235.00 | Low | View details for Oppenheimer rating of Applied Industrial Technologies (NYSE:AIT) on 4/2/2024 |
MVST Microvast | $0.40 +2.5% | 4/2/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $8.00 -> $4.00 | Low | View details for Oppenheimer rating of Microvast (NASDAQ:MVST) on 4/2/2024 |
MCO Moody's | $372.24 +0.5% | 4/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $411.00 -> $424.00 | Low | View details for Oppenheimer rating of Moody’s (NYSE:MCO) on 4/2/2024 |
SPGI S&P Global | $416.21 +0.1% | 4/2/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $480.00 | Low | View details for Oppenheimer rating of S&P Global (NYSE:SPGI) on 4/2/2024 |
TSLA Tesla | $179.99 -1.8% | 4/2/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Tesla (NASDAQ:TSLA) on 4/2/2024 |
JEF Jefferies Financial Group | $43.22 +0.4% | 4/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $52.00 -> $54.00 | Low | View details for Oppenheimer rating of Jefferies Financial Group (NYSE:JEF) on 4/2/2024 |
ACHV Achieve Life Sciences | $4.52 +3.0% | 4/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $18.00 | Low | View details for Oppenheimer rating of Achieve Life Sciences (NASDAQ:ACHV) on 4/1/2024 |
CALC CalciMedica | $5.96 +4.0% | 4/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $14.00 | Low | View details for Oppenheimer rating of CalciMedica (NASDAQ:CALC) on 4/1/2024 |
CTAS Cintas | $663.59 +0.8% | 4/1/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Cintas (NASDAQ:CTAS) on 4/1/2024 |
DRRX DURECT | $0.97 +1.0% | 4/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $5.00 | Low | View details for Oppenheimer rating of DURECT (NASDAQ:DRRX) on 4/1/2024 |
KALA KALA BIO | $6.95 +1.9% | 4/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $15.00 | Low | View details for Oppenheimer rating of KALA BIO (NASDAQ:KALA) on 4/1/2024 |
CATX Perspective Therapeutics | 1.70 +1.2% | 4/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | 1.20 -> 1.50 | N/A | View details for Oppenheimer rating of Perspective Therapeutics (NYSEAMERICAN:CATX) on 4/1/2024 |
RH RH | $245.00 -0.8% | 4/1/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of RH (NYSE:RH) on 4/1/2024 |
SMTC Semtech | $37.64 +0.1% | 4/1/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Semtech (NASDAQ:SMTC) on 4/1/2024 |
ZURA Zura Bio | $4.15 -2.8% | 4/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $17.00 -> $16.00 | Low | View details for Oppenheimer rating of Zura Bio (NASDAQ:ZURA) on 4/1/2024 |
SG Sweetgreen | $19.90 -11.4% | 4/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $17.00 -> $34.00 | Low | View details for Oppenheimer rating of Sweetgreen (NYSE:SG) on 4/1/2024 |
BRZE Braze | $40.44 -3.5% | 3/28/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $75.00 | Low | View details for Oppenheimer rating of Braze (NASDAQ:BRZE) on 3/28/2024 |
CLRB Cellectar Biosciences | $3.16 +2.3% | 3/28/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $11.00 -> $12.00 | Low | View details for Oppenheimer rating of Cellectar Biosciences (NASDAQ:CLRB) on 3/28/2024 |
POOL Pool | $359.50 -0.8% | 3/28/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $407.00 -> $436.00 | Low | View details for Oppenheimer rating of Pool (NASDAQ:POOL) on 3/28/2024 |
RUM Rumble | $6.70 -5.1% | 3/28/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Rumble (NASDAQ:RUM) on 3/28/2024 |
SPXC SPX Technologies | $121.80 0.0% | 3/28/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $124.00 -> $134.00 | Low | View details for Oppenheimer rating of SPX Technologies (NYSE:SPXC) on 3/28/2024 |
CXM Sprinklr | $11.95 +2.2% | 3/28/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Sprinklr (NYSE:CXM) on 3/28/2024 |
VRNT Verint Systems | $30.52 +0.8% | 3/28/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Verint Systems (NASDAQ:VRNT) on 3/28/2024 |
IMVT Immunovant | $28.52 +3.9% | 3/28/2024 | Initiated by | Oppenheimer | - | Outperform | $50.00 | Low | View details for Oppenheimer rating of Immunovant (NASDAQ:IMVT) on 3/28/2024 |
XERS Xeris Biopharma | $1.75
| 3/28/2024 | Initiated by | Oppenheimer | - | Outperform | $5.00 | Low | View details for Oppenheimer rating of Xeris Biopharma (NASDAQ:XERS) on 3/28/2024 |
CPRX Catalyst Pharmaceuticals | $15.20 +1.0% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $29.00 | Low | View details for Oppenheimer rating of Catalyst Pharmaceuticals (NASDAQ:CPRX) on 3/27/2024 |
CGTX Cognition Therapeutics | $1.95 +2.1% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $9.00 | Low | View details for Oppenheimer rating of Cognition Therapeutics (NASDAQ:CGTX) on 3/27/2024 |
FRGE Forge Global | $1.91 +4.4% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $3.50 | Low | View details for Oppenheimer rating of Forge Global (NYSE:FRGE) on 3/27/2024 |
PRGS Progress Software | $50.11 +0.6% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $66.00 | Low | View details for Oppenheimer rating of Progress Software (NASDAQ:PRGS) on 3/27/2024 |
STRO Sutro Biopharma | $3.74 +10.3% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $10.00 | Low | View details for Oppenheimer rating of Sutro Biopharma (NASDAQ:STRO) on 3/27/2024 |
WPRT Westport Fuel Systems | $5.25 -3.7% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $19.00 | Low | View details for Oppenheimer rating of Westport Fuel Systems (NASDAQ:WPRT) on 3/27/2024 |
ADBE Adobe | $469.39 +1.4% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $660.00 | Low | View details for Oppenheimer rating of Adobe (NASDAQ:ADBE) on 3/27/2024 |
UPS United Parcel Service | $145.86 -1.1% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $153.00 | Low | View details for Oppenheimer rating of United Parcel Service (NYSE:UPS) on 3/27/2024 |
HCI HCI Group | $114.17 0.0% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $140.00 | Low | View details for Oppenheimer rating of HCI Group (NYSE:HCI) on 3/27/2024 |
VKTX Viking Therapeutics | $76.43 -4.0% | 3/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $116.00 -> $138.00 | Low | View details for Oppenheimer rating of Viking Therapeutics (NASDAQ:VKTX) on 3/26/2024 |
ALSN Allison Transmission | $73.77 +0.3% | 3/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $67.00 -> $90.00 | Low | View details for Oppenheimer rating of Allison Transmission (NYSE:ALSN) on 3/26/2024 |
A Agilent Technologies | $138.70 +1.2% | 3/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $67.00 -> $90.00 | Low | View details for Oppenheimer rating of Agilent Technologies (NYSE:A) on 3/26/2024 |
ADUS Addus HomeCare | $98.40 +2.3% | 3/26/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $118.00 | Low | View details for Oppenheimer rating of Addus HomeCare (NASDAQ:ADUS) on 3/26/2024 |
DYN Dyne Therapeutics | $25.83 +2.1% | 3/26/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $47.00 | Low | View details for Oppenheimer rating of Dyne Therapeutics (NASDAQ:DYN) on 3/26/2024 |
TH Target Hospitality | $11.10 -0.3% | 3/25/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $12.00 -> $10.00 | Low | View details for Oppenheimer rating of Target Hospitality (NASDAQ:TH) on 3/25/2024 |
TSLA Tesla | $179.99 -1.8% | 3/25/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Tesla (NASDAQ:TSLA) on 3/25/2024 |
AMPX Amprius Technologies | $2.01 +7.5% | 3/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $15.00 | Low | View details for Oppenheimer rating of Amprius Technologies (NYSE:AMPX) on 3/22/2024 |
DRI Darden Restaurants | $151.15 -1.5% | 3/22/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $186.00 -> $182.00 | Low | View details for Oppenheimer rating of Darden Restaurants (NYSE:DRI) on 3/22/2024 |
FDS FactSet Research Systems | $419.57 +0.6% | 3/22/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of FactSet Research Systems (NYSE:FDS) on 3/22/2024 |
FDX FedEx | $260.75 -0.4% | 3/22/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of FedEx (NYSE:FDX) on 3/22/2024 |
SHAK Shake Shack | $103.40 -2.3% | 3/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $108.00 -> $120.00 | Low | View details for Oppenheimer rating of Shake Shack (NYSE:SHAK) on 3/22/2024 |
ROP Roper Technologies | $514.76 +0.6% | 3/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $580.00 -> $650.00 | Low | View details for Oppenheimer rating of Roper Technologies (NYSE:ROP) on 3/22/2024 |
He Is Giving Away Bitcoin (Ad) And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously.
Right now is a very important time to pay attention to what we are doing and what is happening.
If you wait... it will be too late.
This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here |
KNF Knife River | $77.74 -0.6% | 3/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $75.00 -> $85.00 | Low | View details for Oppenheimer rating of Knife River (NYSE:KNF) on 3/22/2024 |
DMAC DiaMedica Therapeutics | $2.59 +2.4% | 3/21/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $7.00 -> $6.00 | Low | View details for Oppenheimer rating of DiaMedica Therapeutics (NASDAQ:DMAC) on 3/21/2024 |
TKR Timken | $87.48 -2.0% | 3/21/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $97.00 -> $100.00 | Low | View details for Oppenheimer rating of Timken (NYSE:TKR) on 3/21/2024 |
TOL Toll Brothers | $119.47 +0.3% | 3/21/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $141.00 -> $157.00 | Low | View details for Oppenheimer rating of Toll Brothers (NYSE:TOL) on 3/21/2024 |
TRVI Trevi Therapeutics | $2.86 -2.4% | 3/21/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $9.00 | Low | View details for Oppenheimer rating of Trevi Therapeutics (NASDAQ:TRVI) on 3/21/2024 |
VOR Vor Biopharma | $1.77 +2.9% | 3/21/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $17.00 -> $15.00 | Low | View details for Oppenheimer rating of Vor Biopharma (NYSE:VOR) on 3/21/2024 |
DKS DICK'S Sporting Goods | $198.00 -1.5% | 3/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $190.00 -> $240.00 | Low | View details for Oppenheimer rating of DICK’S Sporting Goods (NYSE:DKS) on 3/20/2024 |
CSL Carlisle Companies | $385.18 -0.8% | 3/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $355.00 -> $405.00 | Low | View details for Oppenheimer rating of Carlisle Companies (NYSE:CSL) on 3/20/2024 |
CRNX Crinetics Pharmaceuticals | $45.05 +2.8% | 3/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $54.00 -> $55.00 | Low | View details for Oppenheimer rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 3/20/2024 |
EQIX Equinix | $695.33 -2.2% | 3/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $875.00 -> $950.00 | Low | View details for Oppenheimer rating of Equinix (NASDAQ:EQIX) on 3/20/2024 |
NVDA NVIDIA | $830.41 -3.9% | 3/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $850.00 -> $1,100.00 | Low | View details for Oppenheimer rating of NVIDIA (NASDAQ:NVDA) on 3/20/2024 |
CRVS Corvus Pharmaceuticals | $1.61 +3.9% | 3/20/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $8.00 -> $7.00 | Low | View details for Oppenheimer rating of Corvus Pharmaceuticals (NASDAQ:CRVS) on 3/20/2024 |
STEP StepStone Group | $35.49 -1.6% | 3/20/2024 | Initiated by | Oppenheimer | - | Outperform | $48.00 | Low | View details for Oppenheimer rating of StepStone Group (NASDAQ:STEP) on 3/20/2024 |
GRWG GrowGeneration | $2.45 -18.1% | 3/20/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of GrowGeneration (NASDAQ:GRWG) on 3/20/2024 |
C Citigroup | $61.35 +0.0% | 3/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $95.00 -> $88.00 | Low | View details for Oppenheimer rating of Citigroup (NYSE:C) on 3/19/2024 |
CATX Perspective Therapeutics | 1.70 +1.2% | 3/19/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | 1.20 | N/A | View details for Oppenheimer rating of Perspective Therapeutics (NYSEAMERICAN:CATX) on 3/19/2024 |
GS The Goldman Sachs Group | $426.54 0.0% | 3/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $506.00 -> $446.00 | Low | View details for Oppenheimer rating of The Goldman Sachs Group (NYSE:GS) on 3/19/2024 |
JPM JPMorgan Chase & Co. | $191.86 +0.1% | 3/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $238.00 -> $219.00 | Low | View details for Oppenheimer rating of JPMorgan Chase & Co. (NYSE:JPM) on 3/19/2024 |
MS Morgan Stanley | $91.49 +0.7% | 3/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $109.00 -> $97.00 | Low | View details for Oppenheimer rating of Morgan Stanley (NYSE:MS) on 3/19/2024 |
USB U.S. Bancorp | $41.05 +1.0% | 3/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $61.00 -> $55.00 | Low | View details for Oppenheimer rating of U.S. Bancorp (NYSE:USB) on 3/19/2024 |
WFC Wells Fargo & Company | $59.50 +0.3% | 3/19/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Wells Fargo & Company (NYSE:WFC) on 3/19/2024 |
ALPN Alpine Immune Sciences | $64.60 +0.0% | 3/19/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $33.00 -> $44.00 | Low | View details for Oppenheimer rating of Alpine Immune Sciences (NASDAQ:ALPN) on 3/19/2024 |
BAC Bank of America | $36.95 -0.2% | 3/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $50.00 -> $46.00 | Low | View details for Oppenheimer rating of Bank of America (NYSE:BAC) on 3/19/2024 |
MOD Modine Manufacturing | $92.28 -0.4% | 3/19/2024 | Initiated by | Oppenheimer | - | Outperform | $105.00 | Low | View details for Oppenheimer rating of Modine Manufacturing (NYSE:MOD) on 3/19/2024 |
CRBP Corbus Pharmaceuticals | $37.25 +0.6% | 3/13/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $51.00 -> $58.00 | Low | View details for Oppenheimer rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 3/13/2024 |
CRNX Crinetics Pharmaceuticals | $45.05 +2.8% | 3/13/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $48.00 -> $54.00 | Low | View details for Oppenheimer rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 3/13/2024 |
DRI Darden Restaurants | $151.15 -1.5% | 3/13/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $186.00 | Low | View details for Oppenheimer rating of Darden Restaurants (NYSE:DRI) on 3/13/2024 |
RRX Regal Rexnord | $160.21 -0.7% | 3/13/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $185.00 -> $210.00 | Low | View details for Oppenheimer rating of Regal Rexnord (NYSE:RRX) on 3/13/2024 |
TRMB Trimble | $58.59 -2.5% | 3/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $65.00 -> $72.00 | Low | View details for Oppenheimer rating of Trimble (NASDAQ:TRMB) on 3/14/2024 |
NYXH Nyxoah | $9.48 -8.4% | 3/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $17.00 -> $20.00 | Low | View details for Oppenheimer rating of Nyxoah (NASDAQ:NYXH) on 3/14/2024 |
ADBE Adobe | $469.39 +1.4% | 3/15/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $660.00 | N/A | View details for Oppenheimer rating of Adobe (NASDAQ:ADBE) on 3/15/2024 |
LEN Lennar | $152.42 +0.5% | 3/15/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | N/A | View details for Oppenheimer rating of Lennar (NYSE:LEN) on 3/15/2024 |
MDGL Madrigal Pharmaceuticals | $210.59 +3.2% | 3/15/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $320.00 -> $375.00 | N/A | View details for Oppenheimer rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 3/15/2024 |
PTMN Portman Ridge Finance | $19.15 -2.0% | 3/15/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | $20.00 | N/A | View details for Oppenheimer rating of Portman Ridge Finance (NASDAQ:PTMN) on 3/15/2024 |
SEIC SEI Investments | $66.21 +0.4% | 3/15/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $73.00 -> $77.00 | N/A | View details for Oppenheimer rating of SEI Investments (NASDAQ:SEIC) on 3/15/2024 |
SMAR Smartsheet | $38.50 +1.8% | 3/15/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $60.00 -> $55.00 | N/A | View details for Oppenheimer rating of Smartsheet (NYSE:SMAR) on 3/15/2024 |
URGN UroGen Pharma | $14.40 +4.2% | 3/15/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $35.00 -> $34.00 | N/A | View details for Oppenheimer rating of UroGen Pharma (NASDAQ:URGN) on 3/15/2024 |
WSM Williams-Sonoma | $283.62 -1.1% | 3/15/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | N/A | View details for Oppenheimer rating of Williams-Sonoma (NYSE:WSM) on 3/15/2024 |
EW Edwards Lifesciences | $84.23 -0.5% | 3/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $93.00 -> $100.00 | Low | View details for Oppenheimer rating of Edwards Lifesciences (NYSE:EW) on 3/18/2024 |
WCN Waste Connections | $162.08 0.0% | 3/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $170.00 -> $180.00 | Low | View details for Oppenheimer rating of Waste Connections (NYSE:WCN) on 3/18/2024 |
VTYX Ventyx Biosciences | $4.68 +25.1% | 3/12/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $12.00 | Low | View details for Oppenheimer rating of Ventyx Biosciences (NASDAQ:VTYX) on 3/12/2024 |
NFLX Netflix | $551.71 +0.2% | 3/11/2024 | Target Raised by | Oppenheimer | - | Outperform | $615.00 -> $725.00 | Low | View details for Oppenheimer rating of Netflix (NASDAQ:NFLX) on 3/11/2024 |
RWAY Runway Growth Finance | $12.88 +1.8% | 3/8/2024 | Reiterated by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Runway Growth Finance (NASDAQ:RWAY) on 3/8/2024 |
FIGS FIGS | $5.08 -0.6% | 3/8/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of FIGS (NYSE:FIGS) on 3/8/2024 |
FROG JFrog | $39.48 -1.0% | 3/7/2024 | Target Raised by | Oppenheimer | - | | $41.00 -> $48.00 | Low | View details for Oppenheimer rating of JFrog (NASDAQ:FROG) on 3/7/2024 |
EHAB Enhabit | $10.19 +1.0% | 3/7/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Enhabit (NYSE:EHAB) on 3/7/2024 |
JSPR Jasper Therapeutics | $23.99 +0.5% | 3/7/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $80.00 | Low | View details for Oppenheimer rating of Jasper Therapeutics (NASDAQ:JSPR) on 3/7/2024 |
MRNS Marinus Pharmaceuticals | $1.47 +4.3% | 3/7/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | $9.00 | Low | View details for Oppenheimer rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 3/7/2024 |
PNR Pentair | $79.07 0.0% | 3/7/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $82.00 -> $88.00 | Low | View details for Oppenheimer rating of Pentair (NYSE:PNR) on 3/7/2024 |
RSI Rush Street Interactive | $6.41 +0.3% | 3/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $7.00 -> $9.00 | Low | View details for Oppenheimer rating of Rush Street Interactive (NYSE:RSI) on 3/7/2024 |
WCC WESCO International | $154.25 +1.0% | 3/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $175.00 -> $190.00 | N/A | View details for Oppenheimer rating of WESCO International (NYSE:WCC) on 3/7/2024 |
AOMR Angel Oak Mortgage REIT | $10.86 +3.1% | 3/6/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Angel Oak Mortgage REIT (NYSE:AOMR) on 3/6/2024 |
CNNE Cannae | $19.41 -0.2% | 3/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $25.00 -> $27.00 | Low | View details for Oppenheimer rating of Cannae (NYSE:CNNE) on 3/6/2024 |
CHPT ChargePoint | $1.42 +6.8% | 3/6/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of ChargePoint (NYSE:CHPT) on 3/6/2024 |
BASE Couchbase | $24.22 +0.3% | 3/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $25.00 -> $36.00 | Low | View details for Oppenheimer rating of Couchbase (NASDAQ:BASE) on 3/6/2024 |
CRWD CrowdStrike | $295.44 +1.0% | 3/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $300.00 -> $355.00 | N/A | View details for Oppenheimer rating of CrowdStrike (NASDAQ:CRWD) on 3/6/2024 |
DG Dollar General | $137.58 -1.2% | 3/6/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Dollar General (NYSE:DG) on 3/6/2024 |
HCP HashiCorp | $32.62 +0.5% | 3/6/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $34.00 | Low | View details for Oppenheimer rating of HashiCorp (NASDAQ:HCP) on 3/6/2024 |
IONS Ionis Pharmaceuticals | $43.01 +4.2% | 3/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $65.00 -> $72.00 | Low | View details for Oppenheimer rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 3/6/2024 |
MCRB Seres Therapeutics | $1.08 +9.1% | 3/6/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $9.00 -> $5.00 | Low | View details for Oppenheimer rating of Seres Therapeutics (NASDAQ:MCRB) on 3/6/2024 |